coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Liga Wigan PCN, Wigan (LAD) · Health Inequalities Profile

    PCN U23418 · NHS Greater Manchester Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    41,852

    Registered population

    60.8% aged 18–64

    19.9%

    Aged 65+

    ICB 14.9% · England 17.9%

    14.5%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~5,550

    Core20 residents (est.)

    Resident basis; registered basis ~6,420 · see page 3

    7,622

    Hypertension register

    +9.31% in 3 yrs · England +5.60%

    446

    SMI register

    12.5% of Wigan (LAD)'s

    807

    COPD register

    Reviews +4.82% in 3 yrs

    Forecast to 2030

    9,595

    Hypertension patients, 2030

    +1,973 on today

    68.0%

    QRISK ≥20% on statins, 2030

    +3.43pp over 3 yrs

    4.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -4.2%
    COPD and learning disability registers fell.

    Over 2023 to 2025, COPD prevalence fell 4.2% (England +2.6%) and learning disability fell 3.5% (England +5.4%), which could reflect unverified coding gaps.

    60.5%
    Lipid-lowering therapy trails comparators.

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 60.5%, below England (63.6%), Wigan (LAD) (64.0%) and the ICB (67.0%).

    75.3%
    Strong blood pressure and COPD reviews.

    Hypertension patients treated to target reach 75.3% (England 70.3%) and COPD annual reviews reach 84.0% (England 76.4%), showing strong register delivery.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older residents make up 19.9% of the PCN, exceeding borough and England benchmarks

    Liga Wigan PCN covers 41,852 registered patients. Patients aged 65+ account for 19.9% (8,323 patients), above Wigan (LAD) (18.8%), NHS Greater Manchester Integrated Care Board (14.9%) and England (17.9%). Children aged 0–17 represent 19.3% (8,091 patients), below Wigan (LAD) (20.0%), the ICB (21.8%) and England (19.6%). Gypsy or Irish Traveller residents represent 0.1% (LAD 0.1%, ICB 0.1%, England 0.1%) and Roma residents 0.1% (LAD 0.1%, ICB 0.1%, England 0.2%). Projected list growth of 2.6% to 2030 exceeds Wigan (LAD) (1.1%), the ICB (1.6%) and England (2.3%), though projection methodology is unverified.

    Age profile

    0–1719.3%
    18–6460.8%
    65+19.9%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Wigan (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wigan LA)2,7062,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.3%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)61.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wigan LA)1,2431,0219552024/25
    Falls deaths, all ages, per 100,000 (Wigan LA)12.318.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is below England overall, yet practice Core20 share spans 16.7 percentage points

    The PCN’s Core20 share is 14.5%, below Wigan (LAD) at 29.4%, NHS Greater Manchester Integrated Care Board at 40.7%, and England at 21.0%. Modelled practice shares average a weighted 15.3%, showing a base reconciliation discrepancy against the PCN figure. Practice concentration spans 16.7 pp, from 8.4% at Ssp Health Limited Ashton Medical Centre to 25.1% at Shahbazi Ss. Three practices exceed England, led by Shahbazi Ss (25.1%), while Lowton & Platt Bridge Surgery carries the highest estimated volume at 1,115 Core20 patients (19.6% share).

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Shahbazi Ss25.1% · 771 patients
    Golborne24.6% · 721 patients
    High Street24.0% · 1,083 patients
    Lowton & Platt19.6% · 1,115 patients
    Slag Lane MC14.6% · 885 patients
    Bryn Street10.5% · 671 patients
    Braithwaite Rd9.6% · 481 patients
    Ssp Health8.4% · 693 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    446

    SMI register

    1.07% recorded prevalence

    283

    Learning disability register

    0.68% recorded prevalence

    11

    Care homes, 505 beds

    In the PCN catchment

    10.1%

    Provide unpaid care

    Wigan (LAD), Census 2021

    Recorded severe mental illness includes 446 patients (1.1%, vs Wigan (LAD) 1.0%, ICB 1.1% and England 1.0%), and learning disability includes 283 patients (0.7%, vs Wigan (LAD) 0.7%, ICB 0.6% and England 0.6%). The PCN catchment includes 11 care homes holding 505 beds.

    Severe mental illness: physical health checks

    Recorded blood pressure checks for patients with severe mental illness reached 90.0% (England 83.4%) and BMI checks reached 92.1% (England 82.1%). Blood pressure check recording rose +3.5 pp over 2023 to 2025 (England +4.4 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,622

    Hypertension register

    +9.31%

    Register growth, 3 yrs

    Wigan (LAD) +10.59% · England +5.60%

    +3.53pp

    BP control, under 80

    ≤140/90 · +4.45pp aged 80+

    +1,973

    More patients by 2030

    Forecast 9,595 (21.75%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.2% (7,622 patients), in line with Wigan (LAD) (18.0%), above NHS Greater Manchester Integrated Care Board (14.4%) and England (15.2%). Over 2023 to 2025, prevalence grew +9.3% (+1.6 pp). Blood pressure control is strong: 75.3% of patients are treated to target (England 70.3%) and 72.5% aged under 80 achieve target (England 67.8%). Recent blood pressure checks reach 91.7% (England 90.0%). Practice prevalence ranges from 16.1% at Ssp Health Limited Ashton Medical Centre to 22.3% at High Street Surgery. Blood pressure control above national and ICB averages shows strong management, meaning the PCN should prioritise sustaining recall and treatment protocols.

    Lipids and statins

    Patients with QRISK ≥ 20% treated with lipid lowering therapy reached 60.5%, trailing England (63.6%), Wigan (LAD) (64.0%) and NHS Greater Manchester Integrated Care Board (67.0%). Similarly, statin treatment for diabetic patients with CVD is 83.2% (England 84.4%). Proactive recall of high-risk patients remains the key clinical priority to close secondary prevention gaps.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202677,156£1.90£1.94£1.86£146,596
    Cardiovascular (all), 2025116,027£4.20£3.15£3.33£487,313

    For lipid-regulating drugs in 2026, the PCN prescribed 77,156 items at £1.90 per item (£146,596 spend). This was £3,086 more than at England's unit cost (£1.86), but £3,086 less than at NHS Greater Manchester Integrated Care Board's unit cost (£1.94). With unit costs close to benchmarks, expanding treatment reach to untreated high-risk patients takes priority over unit-cost adjustments.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +2.80%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −2.82%

    Asthma prevalence, PCN 3-yr % change

    COPD recorded prevalence is 1.9% (807 patients), matching England (1.9%) but below Wigan (LAD) (2.6%). Over 2023 to 2025, COPD prevalence fell 4.2% (England +2.6%, Wigan (LAD) +6.2%), which may reflect detection gaps that clinical audit would test. COPD reviews reach 84.0% (England 76.4%). Asthma prevalence is 7.2% (2,819 patients; England 6.6%), with reviews at 69.7% (England 65.7%), leaving 855 patients without a recorded review. Asthma management items prescribed reached 2,342 per 1,000 population aged 5–19 (England 1,488).

    Cancer register and children's immunisation

    The cancer register records 1,578 patients (3.8%, matching England 3.8%). In Q1 2025/26, 6-in-1 coverage at 12 months reached 97.8%, and MMR dose 1 at age 5 reached 97.3%, exceeding the 95.0% target. However, age-5 booster coverage was lower: MMR dose 2 reached 90.9% (6.4 pp below dose 1 and 4.1 pp below the 95.0% target), while the 4-in-1 pre-school booster reached 90.0% (5 pp below the 95.0% target).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.8%

    England 91.0%

    6-in-1 complete primary course at 24 months95.0%

    England 92.2%

    MMR dose 1 at 24 months95.0%

    England 88.3%

    MMR dose 2 at age 590.9%

    England 82.8%

    4-in-1 pre-school booster at age 590.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, across NHS Greater Manchester ICB, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2, matching England (55.3%) but 19.4 percentage points below the 75.0% 2028 ambition. Staging coverage was 70.8% across 16,492 registrations (England 67.0%), meaning unrecorded stage limits precision. Between 2013 and 2022, early-stage share rose +3.1 percentage points from 52.4%, leaving a regional gap of about 2,270 extra early diagnoses annually to achieve 75.0%. PCN cervical screening is 74.7% (England 66.8%), though Golborne Surgery records 60.0%. These wider system figures do not measure PCN performance, but require practices to sustain screening coverage.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, 82.798% of patients met the 28-day faster diagnosis standard, 7.8 pp above the 75.0% standard. However, the trust achieved 76.7801% against the 85.0% 62-day referral to treatment standard (8.2 pp below) and 89.041% on the 96.0% 31-day combined standard (7.0 pp below). Across NHS Greater Manchester Integrated Care Board, 28-day faster diagnosis reached 79.5261% (4.5 pp above), 62-day treatment was 75.7262% (9.3 pp below), and 31-day treatment was 96.4937% (0.5 pp above). Secondary care treatment delays mean PCN clinicians must maintain proactive referral safety-netting.

    Pathways within standard (%)Wrightington, Wigan and LeighMersey and West LancashireNorth Cheshire and MerseyGreater Manchester ICBEngland
    28-day faster diagnosis (75%)82.8072.3980.2179.5379.32
    31-day treatment (96%)89.0495.4698.1796.4992.50
    62-day referral to treatment (85%)76.7877.9683.6775.7371.16
    Diagnostic waits over 6 weeks (%)Wrightington, Wigan and LeighMersey and West LancashireNorth Cheshire and MerseyEngland
    MRI0.4914.040.5321.40
    CT7.7813.082.329.92
    Echocardiography24.3734.8828.0428.48
    Colonoscopy6.1018.0415.9830.83
    Gastroscopy12.5418.1720.2429.02
    All 15 DM01 tests14.3621.176.3423.14
    Community services activityWigan residentsGreater Manchester ICB
    Care contacts48,150573,310
    Referrals13,75094,470
    Patients with a contact18,695183,535

    Community services (residents of Wigan), Jun 2026 (provisional). In the Community Services Dataset for Jun 2026 (provisional), adults aged 65+ accounted for 58.5% of community contacts among borough residents (28,190 of 48,150 contacts). These borough-level resident figures describe system activity rather than PCN delivery, highlighting where multidisciplinary community coordination can support older patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient satisfaction spans 27.4 percentage points and vaccination achievement spans 75.5 percentage points

    In 2025/26, QOF overall achievement was 88.2% at Shahbazi Ss and 88.2% at High Street Surgery, whereas Slag Lane MC achieved 100.0%, compared with an England level of 92.5%. For QOF vaccination and immunisation-domain achievement, the range between captured practices was 75.5 pp, with Golborne Surgery recording 24.5% and Slag Lane MC recording 100.0%, compared with 55.2% across England.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    High Street13224.081.1%71.8%89.0%
    Slag Lane MC9314.673.8%62.0%84.6%
    Bryn Street11510.572.3%76.9%84.5%
    Lowton & Platt9719.672.0%84.2%81.0%
    Shahbazi Ss11725.176.4%80.6%77.7%
    Braithwaite Rd1139.658.9%85.3%75.9%
    Ssp Health948.456.1%76.5%67.9%
    Golborne Surgery8324.660.6%72.3%61.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWigan (LAD)AssetPCNWigan (LAD)
    Care homes (catchment)11 (505 beds)n/aSchools (catchment)45n/a
    Children's centres420Places of worship36164
    Libraries110Primary schools (LA maintained)1368
    Primary academies421Special schools13

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    COPD register case-finding audit

    COPD prevalence is 1.9% (807 of 41,852 patients; England 1.9%, Wigan (LAD) 2.6%), falling 4.2% over 2023 to 2025 (England +2.6%), a modelled range of -14 to +269 patients. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 2

    Age-five pre-school booster recall

    In Q1 2025/26 (cohort 110), age-5 MMR2 is 90.9% (6.4 pp below MMR1 at 97.3%; 4.1 pp below the 95.0% target) and 4-in-1 is 90.0% (5 pp below target). For discussion, practices could audit age-five cohorts for unrecorded second MMR and 4-in-1 doses and offer flexible pre-school catch-up clinic slots. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Learning disability register validation

    Learning disability prevalence is 0.7% (283 patients; Wigan (LAD) 0.7%, England 0.6%), with a 3-year change of -3.5% over 2023 to 2025 versus growth in England (+5.4%) and Wigan (LAD) (+2.2%). Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI check audit (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Sustain blood pressure control (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Access and triage workflow review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · COPD register case-finding audit (p12)COPD register · COPD: QOF prevalence · Registered populationCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 2 · Age-five pre-school booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15